In a previous study performed by us, functional alterations in the inspiratory muscles were evaluated in patients receiving corticosteroids for diseases other than respiratory. We have shown that patients who received high-dose steroids for several weeks developed inspiratory muscle weakness that was reversible following withdrawal of the drug treatment. The present study was designed to evaluate the ability of specific inspiratory muscle training (SIMT) to prevent the effects of a therapeutic dosage of corticosteroids on inspiratory muscle function in patients receiving the drug for diseases other than pulmonary, with no underlying respiratory or muscular disease. Twelve patients, 5 men and 7 women, with ages ranging from 19 to 41 years, who received corticosteroids for diseases other than respiratory were recruited into two groups: 6 patients were assigned to the control group and got sham training and 6 patients received SIMT while receiving corticosteroids in a single-blind group-comparative trial. In both groups, there was no difference between the posttreatment and pretreatment values as regard to the FEV1/FVC relationship. However, in the control group but not in the training group, there was a small but significant decrease, from 99.2 ± 3.0 to 94.3 ± 2.8 (mean ± SEM, p<0.01) in FEV1 (percent of predicted n a recent study,' we have shown that patients who received high-dose steroids for several weeks developed inspiratory muscle weakness, which seemed to be reversible following withdrawal of the drug treatment. We were able to eliminate some of the problems that limit the interpretation of the impact of corticosteroids on inspiratory muscle performance by choosing patients with no underlying pulmonary disease and with normal pulmonary and respiratory muscle function.
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A number of studies have been carried out to correlate dyspnea and respiratory muscle performance. It It is well established that respiratory muscles can be trained, even in healthy subjects, like other skeletal muscles, and several reviews have been published dealing with ventilatory muscle training.8"11
We hypothesized that specific inspiratory muscle training (SIMT) would prevent steroid-induced inspiratory muscle weakness and dyspnea in patients with no underlying pulmonary disorder.
This study was designed to evaluate the ability of SIMT to prevent the effects of a therapeutic dosage of corticosteroids on inspiratory muscle function in patients receiving the drug for diseases other than pulmonary with no underlying respiratory or muscular disease.
METHODS
Twelve consecutive patients, 5 men and 7 women, with ages Inspiratory Muscle Endurance: To determine inspiratory muscle endurance, a device similar to that proposed by Nickerson and Keens'3 was used. Subjects inspired through a two-way valve (Hans-Rudolph) whose inspiratory port was connected to a chamber and plunger to which weights could be added externally. Inspiratory threshold load was then increased by the progressive addition of 25-to 100-g weights at 2-min intervals, as was previously described by Martyn and coworkers,'4 until the subjects were exhausted and could no longer inspire. The pressure achieved with the heaviest load (tolerated for at least 60 s) was defined as the peak pressure (PmPeak).
Training Protocol: Subjects of both groups trained five times a week, each session consisting of 30 min of training, while receiving corticosteroids. The training was performed under the supervision of a physiotherapist. Both groups received the same attention and adjustment in medications and were managed equally during the training period.
In the SIMT group, subjects started to train with a resistance equal to 15% of their Plmax, and the resistance was then increased incrementally to 60% of their Plmax, through the first month. The SIMT was then continued at 60% of the Plmax. The level of load was adjusted every week according to the new measurements of the Plmax achieved by the patients. Patients in group A breathed through the same trainer with no resistance. The subjects received either SIMT or a sham training with a threshold inspiratory muscle trainer (Threshold Inspiratory Muscle Trainer, Healthscan, NJ).
Patients in both groups were highly motivated and highly compliant with the training. Even the control patients continued using the sham training to the end of the study. However, most of the patients in the control group became gradually aware of the fact that they were using a sham device, but there was no interaction between the two groups.
Data Analysis
The paired t tests were used to compare posttreatment with respect to pretreatment values. The analysis of variance was carried out to compare changes exhibited by the two groups.
RESULTS
Spirometry data for the two groups before treatment are also presented in Table 1 (Fig 1) . '1920 In a study recently performed by us, we reported that administration of corticosteroids to eight patients with normal lung and respiratory muscle function, for 8 weeks, resulted in a moderate reduction in inspiratory muscle strength (from 126.9 ± 9.6 to 86.5 ± 7.4 cm H20, p<0.0001) and striking reduction in endurance (from 84.4 ± 2.4 to as low as 38.9 ± 2.4%, p<0.0001). A number of studies have been carried out to correlate dyspnea and respiratory muscle performance. It was well documented that the intensity of breathlessness is related not only to the activity, but also to the strength of the inspiratory muscles.2-4 Corticosteroids in high doses and for prolonged periods are frequently used in the treatment of many pulmonary diseases,19-21 and the potential myopathic effect of the drug on the respiratory muscles, as was observed in our study, is of great relevance to patients, like patients with COPD already suffering from dyspnea due to their underlying respiratory disorder. In addition, asthmatic patients treated with long-term corticosteroids might be disadvantaged during asthma attacks when the increased work of breathing demands further muscle effort. In such cases, the potential benefits of corticosteroids on lung function may be overshadowed by their negative effect on inspiratory muscle function.
It has been shown previously that the inspiratory muscles can be trained for both strength and endurance in normal subjects,1" quadriplegics,22 patients with cystic fibrosis, and patients with COPD. [23] [24] [25] The new threshold inspiratory muscle trainers are designed to provide a specific, constant workload that is independent of variations in inspiratory flow rate. In two previous studies, we were able to demonstrate that all patients who trained with threshold trainer were able to increase their inspiratory muscle strength and endurance.26,27 The present study clearly shows that inspiratory muscle training abolished completely the adverse effect of the corticosteroids on the inspiratory muscles. Corticosteroids play a major role in the treatment of COPD, asthma, and other pulmonary diseases, some of them already being characterized by inspiratory muscle weakness and dyspnea. In such cases, to prevent the adverse effect of the drug, SIMT might be recommended along with the treatment.
